Why the study?
The study aimed to analyze the relationship between coronary artery damage and the development of cardiac rhythm and conduction changes in patients with chronic coronary heart disease and type 2 diabetes mellitus.
Is type 2 diabetes mellitus associated with a higher frequency of cardiac arrhythmias and conduction disorders related to coronary artery lesions in patients with coronary artery disease?
Is type 2 diabetes mellitus associated with a higher frequency of cardiac arrhythmias and conduction disorders related to coronary artery lesions in patients with coronary artery disease?
In patients with coronary artery disease, concomitant type 2 diabetes is associated with a higher frequency of atrioventricular and right bundle branch blocks related to right coronary artery lesions.
May warrant arrhythmia vigilance in diabetic CAD; observational data leaves clinical impact open.
Aim . To analyze the relationship between coronary artery damage and the development of changes in cardiac rhythm and conductivity in patients with chronic coronary heart disease and type 2 diabetes mellitus. Material and methods . A cross-sectional retrospective observational study was conducted among 222 patients with diagnosed coronary artery disease, the patients were divided into 2 groups: 126 patients with coronary artery disease and type 2 diabetes and 96 patients with coronary artery disease without carbohydrate metabolism disorders. Statistical processing was performed using IBM SPSS Statistics Version 25.0, nonparametric statistical methods were used. Results . In patients of the main group, there was a more frequent association of right coronary artery lesions with the presence of atrioventricular block (p = 0,021) and right bundle branch block (p = 0,019). Conclusion . The analysis demonstrated that in patients with coronary heart disease in combination with type 2 diabetes, coronary artery disease is an important link in the pathogenetic chain of cardiac arrhythmias and conduction disorders. The results obtained emphasize the need to use comprehensive methods to assess the risk of arrhythmias in patients with various clinical variants of coronary heart disease, especially in the presence of concomitant metabolic disorders such as type 2 diabetes mellitus.
No takes yet. Share an insight, caveat, or question.
Motorina et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: